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Abstract: The aim of this work was to organize the first proficiency test (PT) dedicated to
staphylococcal enterotoxin B (SEB) detection in milk and buffer solutions. This paper describes
the organization of the PT trial according to EN ISO 17043 requirements. Characterization of
the SEB stock solution was performed using SDS-PAGE and SE-specific ELISA, and amino acid
analysis was used to assign its protein concentration. The solution was then used to prepare six PT
materials (four milk and two buffer batches) at a ng/g toxin level, which included one blank and one
SEA-containing milk as specificity control. Suitable material homogeneity and stability were assessed
using screening and quantitative ELISAs. Among the methods used by the participants, ELISA-based
methods demonstrated their efficiency for the detection of SEB in both simple and complex matrices.
The results serve as a basis for further improving the detection capabilities in expert laboratories and
can therefore be considered as a contribution to biopreparedness.
Keywords: staphylococcal enterotoxin B; bioterrorism agent; proficiency test; ELISA methods
1. Introduction
Bacterial toxins represent the third most common causative agent of reported foodborne outbreaks
within the European Union (EU), with staphylococcal enterotoxins (SEs) being considered as a major
cause of foodborne illness due to bacterial toxins (i.e., 49% of cases over the period 2010–2014) [1–5].
The notifications of SEs in food matrices have been mandatory since 2005 (Commission Regulation
(EC) No. 2073/2005 amended by EC No. 1441/2007). SEs are at the interface of classical biological and
chemical agents. Among the 23 SEs serotypes, staphylococcal enterotoxin type B (SEB) could be used
for terrorist attacks on the basis of its availability, ease of preparation, high toxicity, and/or lack of
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medical countermeasures. As ricin, botulinum neurotoxins, and saxitoxin, SEB is considered among the
most relevant agents in the bioterrorism, for which the current preparedness within European countries
should be further improved to control and to limit casualties in the case of an intentional release.
Coagulase positive staphylococci (CPS) are widespread bacteria commonly found in the
environment and borne by some animals such as mammals and birds. SEB is a 28.336 kDa heat
stable protein produced by enterotoxigenic strains of CPS, mainly Staphylococcus aureus. It is known
as a causative agent of food-borne outbreaks, mainly as a result of food contaminated with
Staphylococcus aureus. However, SEB is also toxic by inhalation and can be easily prepared from
bacterial cultures without the need of specific equipment. Consequently, SEB is listed as a category B
agent of potential bioterrorism risk by the Centers for Disease Control and Prevention (CDC) [6].
Additionally, SEB has a history of military use as a potential warfare agent because it can easily be
aerosolized and can cause shock and death when inhaled at very high dosages. However, it is classified
as an incapacitating agent [7] because in most cases aerosol exposure does not result in death but in a
temporary, though profoundly incapacitating illness. The use of this agent can rapidly overwhelm
the medical infrastructure if it causes large-scale incapacitation [8]. Therefore, SEB is a prohibited
substance under the Biological Weapons Convention (BWC).
Since 2003, the European Union Reference Laboratory for coagulase positive staphylococci (EURL
for CPS) annually organized proficiency test (PT) dedicated to SEs detection according to the EC
regulation [9] but none of them focussed on SEB due to the restrictions for handling and shipment
associated to its classification.
While different methods (generally based on ELISA) for SEB detection and analysis have been
established, there is actually no universal SEB standard available. Generally, PTs and certified reference
materials for the SEB are lacking, as well as standardized validated methods for biosecurity applications.
In this context, the aim of EQuATox project was the Establishment of Quality Assurances for the
Detection of Biological Toxins of Potential Bioterrorism Risk [10]. Expert laboratories from food
safety and security sectors took part this project. To evaluate the capability of the EQuATox network,
laboratories to properly detect SEB in food samples, PT using milk and buffer samples was organized.
Participants were free to use one or more methods, in-house and/or commercially available, routine
and/or recently developed in their laboratories.
This paper describes the characterization of the SEB pure material used as a spiking solution
and the subsequent preparation of homogeneous and stable matrix materials as well as the overall
organization of this first PT to evaluate the SEB detection capability of the participating laboratories.
The paper focuses on the results obtained by the most widely used tools to detect staphylococcal
enterotoxins: immunochemical assays and methods.
2. Results
2.1. Characterization of Toxins
Due to the lack of an available reference material for SEB, there was a crucial need to characterize
and verify the purity of the commercially obtained toxin before organizing the PT trial. In this paper,
we demonstrated that the SEA and SEB toxins purchased from Toxin Technology (Sarasato, FL, USA)
were sufficiently pure to be used for sample preparation. This was accomplished by performing
SDS-PAGE with silver staining and SEA-SEE specific ELISAs (Figure 1). Results obtained highlighted
that the SEB solution used was not as pure as expected considering the quality control certificate
provided by the manufacturer but toxins SEA, SEC, and SED have not been quantified by quantitative
ELISA method used. However, the results confirmed that the purity was sufficiently high to use
LC-ID-MS/MS amino acid analysis (AAA) for establishing a protein quantity value from the SEB
solution, and that this solution was fit-for-purpose to be used as spike for the preparation of suitable
matrix PT materials.
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Figure 1. SDS-PAGE and silver staining of the SEB solution used for spiking.1: SEB solution (Toxin
Technology, Sarasota, FL, USA, Ref BT202 batch number: 91709B); 2: Precision Plus Protein all blue
prestained proteins standards (Biorad, Marnes la coquette, France).
2.1.1. Determination of SEB Protein Concentration by in-House LC-ID-MS/MS AAA
The classical approach of protein quantification by UV-spectrometry and published extinction
coefficients is unspecific (absorbance value only) and thus often questionable. Therefore, protein
quantification was performed using isotopic dilution mass spectrometry (IDMS) as described
elsewhere [11]. SEB was completely hydrolyzed into its principal components, the amino acids.
Subsequently, the six most acid stable amino acids (alanine, proline, valine, leucine, isoleucine, and
phenylalanine) were quantified based on IDMS. Knowledge of the purity and amino acid sequence
composition of the protein of interest allows calculation of the results. The calculations are based
on the quantity of individual amino acids present in the solution. The protein to be analyzed
with this method needs to be sufficiently pure, as otherwise the obtained AAA result cannot be
related to the theoretical sequence of that protein and, thus, are meaningless since the method cannot
differentiate whether a quantified amino acid stems from different proteins in the original sample.
Six independent replicate analyses were performed under repeatability conditions. The obtained
result was 0.125 ± 0.007 mg SEB/mL solution. As the analyzed solution was a carefully prepared
10-fold dilution of the provided stock solution, the SEB content in the stock was thus calculated to
be 1.25 ± 0.07 mg/mL. The resulting variability is expressed as expanded uncertainty (coverage
factor 2), incorporating contributions from repeatability, intermediate precision, calibration, volumetric
dilutions, and among-amino acid variability.
2.1.2. Determination of SEB Protein Concentration by HPLC-FLD of OPA-Derivatized Amino Acids
Three independent samples were prepared and analyzed in duplicate under repeatable conditions.
The result obtained was 0.136± 0.004 mg/mL. As the analyzed solution was a carefully prepared 8-fold
dilution of the stock solution, the SEB content in the stock was thus 1.09 ± 0.03 mg/mL. The results
variability reflects measurement repeatability, but not measurement uncertainty as established for
the other method (see uncertainty contributors above, lines 92–94). As robust estimate of the protein
concentration in the SEB stock solution, the mean of results obtained by AAA and HPLC-FLD methods
was taken, amounting to 1.17 mg/mL. This value was used for spiking the PT trial samples.
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2.1.3. Determination of SEA Protein Concentration by PSAQ Technology
As the SEA solution used for spiking one of the matrix materials in this PT was previously
quantified by the Protein Standard Absolute Quantification (PSAQ) method [12], we did not perform
AAA analysis and used the PSAQ value equal to 0.506 mg/mL to prepare milk sample containing SEA.
2.2. PT Materials Preparation, Homogeneity, and Stability Assessment
Materials were prepared as outlined in the materials and methods section, and were checked for
suitable homogeneity before dispatch to the laboratories (PT round). These results were compared
to those obtained from analysis of randomly selected samples after receiving all the results from the
participants in order to evaluate stability (see below).
Characterization of materials therefore included both homogeneity and stability studies.
Homogeneity data for buffer (B1 and B2) and milk (M2 and M3) samples spiked with SEB are




As  the SEA  solution used  for  spiking one of  the matrix materials  in  this PT was previously 
quantified by the Protein Standard Absolute Quantification (PSAQ) method [12], we did not perform 







































































































































































Homogeneity: Milk (M3) spiked at 25 ng/g
mean=25.88 ng/g
Figure 2. Homogeneity data obtained for the buffer (B1 and B2) and milk (M2 and M3) samples spiked
by SEB. (a): in buffer (B1), (b): in buffer (B2), (c): in milk (M2), (d): in milk (M3).
For the PT material M1 (blank milk), the applied European Screening Method (ESM) using the
VIDAS SET2 detection confirmed the absence of the staphylococcal enterotoxins types SEA, SEB, SEC,
SED, and SEE in e ch of the 20 individual samples analyzed.
SEB was analyzed n PT buffer (B1, B2) and milk (M2, M3 and M4) material by the in-house
quantitative ELISA (limit of detection: 0.06 ng/mL). For m terial B1, B2, M2, and M3 spiked by SEB,
the Relative Standard Deviation (RSD) from 20 individual samples ranged from 3% to 12%. As these
values were lower than 15% (value commonly admitted to define homogeneity in the case of ELISA
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based method), milk (M2, M3) and buffer (B1, B2) samples were considered as homogenous. For PT
material M4 spiked by SEA, SEB was not detected in the 20 individual samples.
The homogeneity test was performed on 20 samples one week before samples dispatch. In order to
assess to stability of SEB in each batch (M1 to M4, B1 and B2), six randomly selected samples were
analyzed after receiving participant results (six weeks after dispatching). Then, these six replicates were
compared to the mean of the 20 values obtained in the homogeneity study (Equation (1)). Results are
presented in Figure 3.
[Buffer 1 recovery]% =
SEB concentration measured in Buffer 1 (stability)
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Figure 3. Stability data obtained for the milk an fer samples spiked by SEB. Data were presented
as recovery calculated from the measured SEB concentrations in stability samples and the assigned
value corresponding to the homogeneity value.
All the data but one replicate (M2 at +29%) were included between lower and upper limits defined
for stability measurement (±25%) (Figure 2). As the aim of this stability study was to demonstrate that
SEB must be detectable over the PT trial period, we considered that this outlier value (+29%) did not
affect the appreciation of samples stability. Therefore:
(a) SEB in the six replicates dedicated to the stability test were well detected and quantified in buffer
(B1 and B2) and milk (M1 a d M2) samples, allowing the consid ration hat the samples were
sufficiently stable when stored at 5 ± 3 ◦C over the PT period.
(b) For material M4 spiked with SEA, SEB was not detected in the six replicates confirming the
absence of cross reactions between the SEA and SEB using the in-house quantitative ELISA.
(c) As in the homogeneity tests, six milk blank samples (M1) were analyzed by the ESM using the
VIDAS SET2 detection assay. Data obtained showed that the five SE types (SEA, SEB, SEC, SED,
and SEE) were not detected, confirming the absence of SEB external contamination in this blank
material (M1).
2.3. PT Trial Organization
The PT trial was organized in five major steps:
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(a) laboratories from the network were invited to participate the PT trial and received information
on the dispatch of samples and the period dedicated for analyzing samples and reporting results
(six weeks).
17 participants confirmed their participation using the ELISA method, but 1 laboratory withdrew
after receiving the samples. Therefore, 16 laboratories took parts in this PT trial using the
ELISA methods.
(b) samples were prepared (Section 5.3) and homogeneity test was performed on 20 replicates for
each material.
(c) (once the homogeneity was confirmed, samples were dispatched on the indicated period, but only
to participants registered for the test.
(d) after receiving the participant results, a stability test was performed for each material on the
six replicates dedicated to this test (Section 5).
(e) received data were assessed, a report was produced and participants received their
individual results.
2.4. Results Obtained by ELISA-Based Methods
15 laboratories provided results with one or more qualitative ELISA based methods (Table 1).
A color-code was used for interpretation:
(a) A green box: Staphylococcal enterotoxins were detected, the serotype SEB was identified in
samples B1 and B2, M2 and M3. For M1 sample (blank), SEs were not detected especially SEB.
For M4 sample (SEA spiked), SEB was not specifically detected.
(b) A light green box: Staphylococcal enterotoxin type SEB was detected in B1, B2, M2, and M3
but other serotypes were identified in these samples. For M1 sample (blank) and M4 samples
(SEA spiked), SEs were not detected without specification of the toxin type.
(c) A red box: false positive or false negative results were obtained.
(d) A white box: samples were not analyzed.
As this study aimed to check the capability of the network to detect SEB, participants were free to
use their own method, based on internal reactive or commercially available detection assays.
In this PT Trial, several qualitative and quantitative in-house ELISA methods were used. Also, eight
commercially available detection assays were tested, including Vidas SET2 (Biomerieux, Marcy l’Étoile,
France), Ridascreen SET ABCDE (Rbiopharm, Darmstadt, Germany), Ridascreen SET Total (Rbiopharm),
Tecra SET VIA (3M, Roseville, New South Wales, Australia), Miprotect SEB (Miprolab, Göttingen,
Germany), SET- RPLA (OXOID, Hampshire, UK), TetraCore ELISA kit (TetraCore, Rockville, MD,
USA), and Portable Toxin Detector pTD (Bruker Daltonik, Leipzig, Germany).
In general, no false positive results were obtained by the network. However, one false negative
result was obtained for M2 (5 ng/g), and five false negative results for B1 (0.5 ng/g). In addition,
among 15 laboratories that used qualitative ELISA (including in-house and commercial assays),
10 laboratories obtained 100% correct results (detection of the serotype SEB by at least one detection
assay), and five laboratories identified correctly the presence of staphylococcal enterotoxins but did
not identify the serotype (i.e., SEB) by at least one detection assay.
Nine laboratories also used quantitative ELISA methods (Table 2) to evaluate the SEB content of
the provided samples.
Toxins 2016, 8, 268 7 of 14
Table 1. Evaluation of the ELISA based qualitative results obtained by participating laboratories.
Lab Code Method Used M1 M2 M3 M4 B1 B2
1
ELISA electrochemical immunosensor—Portable Toxin
Detector pTD (Bruker)
3
Ridascreen SET ABCDE (Rbiopharm)
In house ELISA
4 Vidas SET2 (Biomerieux)
5 Oxoid SET RPLA (Termo Scientific)
6
Vidas SET2 (Biomerieux)
Oxoid SET RPLA (Termo Scientific)
TetraCore ELISA kit (TetraCore)









10 miPROTECT SEB (Miprolab)
11
Vidas SET2 (Biomerieux)
Oxoid SET RPLA (Termo Scientific)
12
Vidas SET2 (Biomerieux)
Tecra SET VIA (3M)
Ridascreen SET Total (Rbiopharm)
In house ELISA [15]
13
Vidas SET2 (Biomerieux)
Oxoid SET RPLA (Termo Scientific)
14
Ridascreen SET ABCDE (Rbiopharm)
TetraCore ELISA kit (TetraCore)
In house ELISA
16 Lateral Flow Assay
17
In house EIA
In house Immunochromatographic Test SEB
A green box: SEB identified in samples B1 and B2, M2 and M3. For M1, SEB specifically not detected. For M4,
SEB not specifically detected, A light green box: SEB detected in B1, B2, M2, and M3 but other serotypes were
identified in these samples. For M1 and M4, SEs were not detected without specification of the toxin type, A red
box: false positive or false negative results were obtained, A white box: samples were not analyzed.
Table 2. Evaluation of quantitative results obtained by ELISA-based methods.
Lab Code Method Used M2 M3 B1 B2
1
ELISA electrochemical immunosensor—Portable
Toxin Detector pTD (Bruker)
3 In house ELISA
7 miPROTECT SEB (Miprolab)
8 In house ELISA







16 Lateral Flow Assay
17 In house EIA
17 In house Immunochromatographic Test SEB
Interpretation: |Z|≤ 2.0 : satisfactory results; 2.0 <|Z|< 3.0 : questionable results; |Z|> 3.0 : unsatisfactory results.
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These results highlighted that the methods used by laboratory coded as 3, 9, 12, and 17 have
reliably quantified SEB in a buffer solution as well as in a complex food matrix. Three out of the
9 laboratories detected and quantified SEB in samples (and SEA in M4), as shown by their Z score≤ 2.0.
In contrast, the method used by laboratory number 16 provided inconsistent quantitative results
compared to the expected ones.
The quantitative assessment showed that the quantitative ELISA methods are the most sensitive.
These are developed generally by the participants using in-house or commercially available antibodies.
3. Discussion
Generally, the most commonly used method for SEs detection in food matrices is based on the use
of anti-enterotoxin polyclonal or monoclonal antibodies. Commercially available assays have been
developed according to two principles:
(a) enzyme immunoassay (EIA) comprising enzyme-linked immunosorbent assay (ELISA) and
enzyme-linked fluorescent assay (ELFA).
(b) reversed passive latex agglutination (RPLA).
The difficulties related to immunological methods for contaminant detection in food matrices
were widely recognized, mainly due to the lack of specificity and sensitivity of the available assay.
Many drawbacks impact the development and use of these techniques for SEs detection in food
matrices. First, highly purified toxins are necessary to produce specific antibodies to develop an EIA;
but they are difficult and expensive to obtain. Also, some commercial kits show a low specificity
where the false positives may occur depending on matrix components as it is well known that some
proteins (e.g., protein A), can interfere with binding to the Fc fragment (and, to a lesser extent,
Fab fragments) in immunoglobulin G from several animal species (e.g., mouse or rabbit, but not rat
or goat). Other interferences are associated with endogenous enzymes, such as alkaline phosphatase
or lactoperoxidase. This paper focuses on the use of such methods to detect SE content in the
provided samples.
Due to drawbacks with currently available detection methods, other strategies based on
physico-chemical techniques have been developed very recently. Among these, mass spectrometry
(MS) has emerged as a very promising and suitable technique for analyzing protein and peptide
mixtures [16]. The development of two soft ionization methods, such as electrospray ionization (ESI)
and matrix-assisted laser desorption/ionization (MALDI), and the use of appropriate mass analyzers
such as time-of flight (TOF), have revolutionized the analysis of biomolecules.
In the case of food analysis, the situation is complex because the matrix can contain many proteins,
lipids and many other molecular species that interfere with the detection of the targeted toxin and may
distort quantification. Sample preparation remains the critical step of the analysis. Few participating
laboratories developed and used mass-spectrometry based method. Even if this work focused on
ELISA method, few laboratories participated to the PT Trial using liquid chromatography coupled mass
spectrometry (LC-MS). SEA and SEB in buffer and milk samples were extracted, purified, and were
digested using Trypsin. Then, the purified extract was analyzed by LC-MS. In fact, SEB specific
peptides were separated in the chromatography column and detected by the MS tool. Among these
methods, one was sufficiently specific to discriminate SEB from other SE types in milk sample but not
sensitive enough to prove SEB presence in buffer solution [17].
The PT samples were prepared according to ISO 17043 and following an internal procedure used
for several years at the EURL for CPS when organizing PT trials among NRLs [18]. The only difference
in the EQuATox PT study was that materials were stored refrigerated and not frozen. The stability study
results described above underline the validity of this approach. Moreover, the acquired homogeneity
and stability results on SEB in these matrix materials point at the possibility for preparing suitable
non-frozen matrix materials for future PT studies, both in the food safety field (“all” SEs), as well as
for biosecurity purposes (SEB detection capability of laboratories). Finally, the obtained stability data
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for SEB provides valuable information for assessing the feasibility for a certified reference material
(CRM) for this toxin in a suitable matrix. Currently, only one CRM, a freeze dried cheese, containing
SEA at two levels was produced recently and is available to the scientific community [19].
Considering the results obtained, the use of commercially available assays allowed reliable
detection of SEB in the tested samples in most cases. Some of them were able to differentiate SEB from
other toxin types whereas others were not. These results highlighted that cross reactions could occur
with the use of two commercially available detection kits which has been already demonstrated [20].
Moreover, analysis of quantitative results highlighted that various in-house methods have the potential
for a reliable quantification of SEB in a buffer solution as well as in a complex food matrix, providing
increased flexibility to the laboratories for enterotoxin quantification.
Some of the commercially available detection methods as well as some of in-house ELISAs
demonstrated their capability to specifically detect and/or quantify SEB in the various types of samples.
4. Conclusions
The results obtained in the SEB PT trial, dealing with the evaluation of the capability of the
EQuATox network laboratories to properly detect SEB in a buffer as well as in a complex food matrix
will contribute to a better understanding and further improvement of the available methods for reliable
detection of this potential bioweapon.
This was accomplished by the preparation of homogeneous materials that showed suitable
stability for the time frame of the study when stored under refrigerated condition. The majority of data
sets obtained were acquired by using immunochemical methods, especially ELISAs. Several of those
ELISAs are commercially available, and some of them allow distinction among SE types SEA-SEE,
whereas others do not allow this distinction and can therefore only be used as screening tools.
Concerning accurate quantification of SEB in buffer and milk samples, some in-house ELISAs showed
suitable performance in a number of laboratories. If properly validated, some of these specific methods
could be made available to designated laboratories in charge of the detection of SEB in various types
of samples. Finally, the described results are valuable to support the development of suitable CRMs
for SE detection in complex matrices.
5. Materials and Methods
5.1. Choice of Samples
Two types of matrices were selected for this PT:
(a) Phosphate buffered saline (NaCl/Na2HPO4: 145 mM/10 mM, Sigma-Aldrich (St. Quentin Fallavier,
France)) at pH 7.3 ± 0.2 was considered as an easy to use matrix.
(b) As the EU regulation 2073/2005 modified by the European regulation 1441/2007 [21] enforces
testing of SEs content in milk and milk based products, it was decided to use liquid UHT fat-free
milk as a complex matrix (purchased from a retail store).
Before starting the samples preparation, the milk matrix was tested for staphylococcal enterotoxin
types SEA to SEE using quantitative ELISAs specific for each of the five toxin types. The results
confirmed the non-detection of SEA–SEE in the milk (<LOD of method). Moreover, a SEA-spiked liquid
milk sample has also been prepared to evaluate the specificity of the methods used by participants.
5.2. Characterization of Toxins
Highly purified freeze-dried SEB (Toxin Technology, Sarasota, FL, Ref BT202 batch number:
91709B) was rehydrated with osmosis water according to the manufacturer’s instructions to obtain
a stock solution with a nominal concentration of 1 mg/mL. Purity of the SEB was assessed after
migration on a 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
stained with Silver nitrate.
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5.2.1. Determination of Protein Concentration of SEB by Amino Acid Analysis (AAA)
In order to characterize and to assign a protein concentration for the SEB stock solution,
two samples were independently characterized by amino acid analysis (AAA) considering a molecular
weight (MW) equal to 28,336 Da [22] in two laboratories:
(a) SGS M-Scan (SGS M-Scan; Freiburg, Germany) [23]. Briefly, Norvaline and Sarcosine were added to
SEB solution as internal standards for primary and secondary amino acids and hydrolyzed in 6 M HCl
at 110 ◦C for 24 h. Then, the obtained solution was analyzed by HPLC with fluorescence detection
following pre-column derivatization with OPA (ortho-phthalaldehyde) with fluorescence
detection at 340/450 nm for excitation and emission, respectively. For calculation of protein
concentrations, only robust amino acids were taken into account as follows;
(b) JRC-IRMM, Geel, Belgium (from EQuATox network). AAA was carried out as described in
detail in the laboratory working instruction of JRC-IRMM and is based on the publication
by Muñoz et al. [11]. Briefly, the protein sample is hydrolyzed using 6 M HCl and 0.1% of
phenol using a 1 h microwave digestion protocol. Liberated amino acids were separated on
a reverse-phase HPLC column and quantified by tandem mass spectrometry using pure amino
acids for calibration and isotopically labelled amino acids as internal standards. Ala, Pro, Val,
Leu, Iso, and Phe are the amino acids which are most stable during hydrolysis and resistant to
oxidation under the conditions employed; these were thus quantified and the results converted
into protein concentration using the published SEB protein sequence [22]. Some deviations
from the validated method were made, for instance: volumetric instead of gravimetric sample
preparation due to safety reasons; employment of lower volumes of toxin, buffer, and internal
standard solutions to allow six independent analyses; and the omission of a so-called sample
blank (sample with all solvents, reagents and internal standards, but without hydrolysis, again
for safety reasons).
However, a so-called reagent blank (solvent, reagents, but no calibrant amino acids and internal
standard isotopically-labelled amino acids; sample undergoing digestion) was included as QC sample
to check for the absence of free amino acids and labelled amino acids in that sample. Moreover,
a second QC (solvent and labelled amino acids, but no calibrant amino acids; sample undergoing
digestion) was included to check for integrity of the internal standard solution (absence of free amino
acids in this solution).
5.2.2. Determination of Protein Concentration of SEA by PSAQ Technology
Highly purified staphylococcal SEA (Technology, Sarasota, FL, USA, Ref AT101, batch number
120794A) used to prepare the M4 sample was previously quantified by nanoLC-ESI-MS/MS using
protein standard absolute quantification (PSAQ) technology [24].
5.3. Preparation of Samples
EURL protocols were used to organize PT trials for the detection of SEs in food matrices in order
to evaluate the capability of EU Member State laboratories to satisfactorily apply the EU regulation.
These PT trials are generally organized using frozen food matrices as it is well known that SEs are
stable. In order to evaluate the stability of SEB in liquid matrices stored at 5 ± 3 ◦C (envisaged storage
conditions for this PT), preliminary experiments were performed. As these results obtained were
satisfactory in terms of homogeneity and stability, we decided to prepare six batches for the PT trial:
(a) blank milk sample (M1),
(b) two milk samples spiked with SEB at 5 ng/g (M2) and 25 ng/g (M3),
(c) one milk sample spiked with SEA at 10 ng/g (M4),
(d) two buffer samples spiked with SEB at 0.5 ng/g (B1) and 2 ng/g (B2) (Figure 4).
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All materials have been prepared according to the requirements of the EN ISO 17043 Standard [25].
For each material, a sufficient number of samples was prepared to perform:
(a) homogeneity (20 samples for each material) and stability studies (6 samples for each material),
(b) dispatch samples dedicated to participants,
(c) additional samples in case of need (10 samples for each material).
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Figure 4. Preparation f the SEB samples.
For each material, 1.4 L of milk were spiked at the targeted SE type/concentration, and aliquoted
in i dividual containers under sterile conditions, it 25.0 g ± 0.1 g per co tainer. During the
spiking step, it was assumed that 1 L of milk c rresponded to 1 g. In total, 53 containers of 25.0 mL
includin homogeneity samples (20 samples), stability samples (6 samples), samples for participants,
and a ditional samples were prepared for each milk material (M1, M2, M3, and M4).
In addition, as for milk samples, a Phosphate buffer/BSA/azide solution was prepared, spiked
with SEB solution and ispatched in individual containers with 1 mL per container. I total,
53 c t i rs f f c ff r t ri l ( ) re repared.
Finally, all containers (participants, hom geneity, stability, and a ditional s mples) were stored
at a temperature of 5 ± 3 ◦C during the t st period. Random codification was used for samples to be
dispatched to participants.
5.4. Hom geneity Study and Determination f Assigned Values
According to EN ISO 13528 [26], 20 containers were randomly taken from each of the six batches
pre ared (M1, M2, M3, M4, B1, and B2). Each sample was quantitatively analyzed once with e
quantita ve ELISA developed in the EURL for CPS except for he blank (M1), which was analyzed by
the so-called European Screening Method (ESM) [18].
The EURL for CPS has been accredited for SEs detection in food matrices according to the EN ISO
CE 17025 Standard (accre itation scope No. 1-2246) [27]. For sample pre aration (homogeneity and
stability tests), an extraction step wa performed according t the ESM. Briefly, all milk samples were
first submitted to a protein ext act on s ep follow d by a dialysis concentrati step overnight against
30% PEG. Then, the obtai ed xtract was analyzed by:
(a) the quantitative ELISA (M2, M3, and M4), which allowed to es ima e the concentration of SEB in
M2 and M3 samples, and to check cross reaction in the case of M4 sample (s iked by SEA).
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(b) the Vidas SET2 detection kit (BioMerieux, Marcy l’Étoile, France), which is able to detect SEA
to SEE in food matrices. Only blank sample M1 was analyzed, in order to check the absence of
contamination of the milk by the 5 SE serotypes (i.e., SEA, SEB, SEC, SED, and SEE) [28,29].
The detection was directly performed on the buffer samples without performing the dialysis
concentration step. When the ESM results were positive, the extracts obtained were submitted to the
in-house quantitative ELISA confirmatory method for SEA to SEE [15].
A single sandwich type was used for SEB whereas double sandwich type ELISA was used for
SEA. For the detection step, specific commercially available antibodies (Toxin Technology, Sarasota,
FL, USA) were used as coating (ref SLAI101 and SLBI202 for SEA and SEB, respectively) and probing
antibodies (ref LAI101 and LBC202 for SEA and SEB, respectively). The presence of toxins was
revealed by immunoglobulins coupled to horseradish peroxidase (ref LBC202 for SEB, and goat
anti-rabbit peroxidase labelled IgG antibodies, KPL) and determined by a colorimetric measurement
at 405/630 nm after addition of ABTS (KPL).
The homogeneity acceptance criterion was defined as follows: 100% of the obtained results above
the LOQ of the quantification method used and a relative standard deviation (RSD) less than or equal
to 15%. For blank and SEA-spiked milk samples (M1 and M4, respectively), 100% of the results
obtained should be below the LOQ of the quantification method used.
5.5. Stability Study of Batches
According to the EN ISO 13528, at least, six replicates per batch were analyzed after receiving all
the participant results. Then, these data were compared to the homogeneity data (performed before
sending samples to participants) in order to check the stability of SEB for the six batches over the
analysis period (6 weeks).
The blank milk (M1) and SEA-spiked milk (M4) samples were considered as stable if the values
obtained during the study period were below the positive threshold of the kit used.
For SEB contaminated samples (B1, B2, M2, and M3) and for each stability point, the calculated
RSD on the six replicates should be below 15%. Values obtained during the stability studies, for each
material, should be equal to the assigned value (corresponding to the homogeneity value) ± 25%.
This 25% value is used by the EURL for CPS in the frame of its PT trial organization and corresponds
to repeatability and reproducibility conditions during the stability testing period.
5.6. Organization of Proficiency Testing
Sixteen laboratories representing 13 EU-countries took part in this SEB proficiency test.
The participant laboratories were invited to use the qualitative, and/or quantitative method(s) currently
used in-house. Most of the participants used ELISA-based methods as these ones are commonly used
to detect and/or quantify proteins from various types of samples.
Due to its classification as dangerous material (IATA 6.1 class), the samples were shipped to each
of the laboratories only upon receiving all the authorizations for the SEB export to each laboratory.
Six encoded samples stored at 5 ± 3 ◦C were shipped under security procedures by World Courier
under refrigeration at positive temperature. Instructions for participants, a report sheet for results,
and an acknowledgment of receipt were included in the parcels. All the samples had been received by
participants within 48 h after dispatching.
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